Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?

R. Van Leeuwaarde, F. Spada, W. Cheung, A. Gonzalez-Clavijo, M. Pracht, G. Emelianova, C. Thirlwell, K. Oberg

Research output: Contribution to journal › Meeting Abstract › Academic

Keywords

@article{b175875a28164e508ce702f7dbb731f0,

title = "Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?",

keywords = "quality of life, gep-net, eortc qlq-ginet21",

author = "{Van Leeuwaarde}, R. and F. Spada and W. Cheung and A. Gonzalez-Clavijo and M. Pracht and G. Emelianova and C. Thirlwell and K. Oberg",

year = "2018",

language = "English",

volume = "106",

pages = "122--122",

journal = "Neuroendocrinology",